Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies

Internal and Emergency Medicine

Volumn 3, Issue 4, 2008, Pages 373-374

  Basili, Stefania ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; HUMAN; LETTER; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; HUMANS; RISK FACTORS;

EID: 55949128462     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0193-4     Document Type: Letter

References (17)

1. S Miyakis MD Lockshin T Atsumi DW Branch RL Brey R Cervera 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295 306
2. IA Naess SC Christiansen SC Cannegieter FR Rosendaal J Hammerstroem 2006 A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study) J Thromb Haemost 4 44 49
3. M Galli D Luciani G Bertolini T Barbui 2003 Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature [review] Blood 101 1827 1832
4. M Galli T Barbui 2003 Antiphospholipid antibodies and thrombosis: strength of association Hematol J 4 180 186
5. JA Giron-Gonzales E Garcia del Rio C Rodriguez 2004 Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals J Rheumatol 31 1560 1567
6. R Forastiero M Martinuzzo G Pombo 2005 A prospective study of antibodies to b2-glycoprotein I and prothrombin and risk of thrombosis J Thromb Haemost 3 1231 1238
7. G Finazzi V Brancaccio M Moia 1996 Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A four-year prospective study from the Italian registry Am J Med 100 530 536
8. KS Ginsburg MH Liang L Newcomer SZ Goldhaber PH Schur CH Hennekens MJ Stampfer 1992 Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis Ann Intern Med 117 997 1002
9. E Somers LS Magder M Petri 2002 Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus J Rheumatol 29 2531 2536
10. JS Berger MC Roncaglioni F Avanzini I Pangrazzi G Tognoni DL Brown 2006 Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 306 313
11. M Gerosa C Chighizola PL Meroni 2008 Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases) Intern Emerg Med 3 201 203
12. G Finazzi 2008 Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No Intern Emerg Med 3 197 200
13. T Hereng M Lambert E Hachulla M Samor S Dubucquoi C Caron D Launay S Morell-Dubois V Queyrel P-Y Hatron 2008 Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients Lupus 17 11 15
14. D Ferro S Basili S Roccaforte M Di Franco F Cipollone G Ciabattoni G Davì 1999 Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus Arthritis Rheum 42 2689 2697
15. D Ferro P Pignatelli L Loffredo F Conti G Valesini A D'Angelo F Violi 2004 Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies Arthritis Rheum 50 1693 1694
16. D Erkan MJ Harrison R Levy M Peterson M Petri L Sammaritano 2007 Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals Arthritis Rheum 56 238 291
17. WH Geerts GF Pineo JA Heit D Bergqvist MR Lassen CW Colwell JG Ray 2004 Prevention of venous thromboembolism: the Seventh ACCP conference on antithrombotic and thrombolytic therapy Chest 126 338S 400S